EGF and breast carcinoma: Exosomes from HEK293 cells stably expressing EGF or EGFR peptide have also been studied as therapeutic agents by targeting breast cancer cells expressing high levels of EGFR (such as the HCC70 breast carcinoma cell line) [39].